Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levopront vs Libexin for Dry Cough in Acute URI
NCT03837938Phase 3Completed
- Sponsor
- Dompé
- Start
- Nov 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Levopront in dry cough (2 arms), sponsored by Dompé. Primary endpoint: Number of Participants With Daytime Cough Resolution Rate at Day 8. Started Nov 2016; status: completed.
02
Drugs
Levopront
03
Conditions
dry cough
Beyond the preview
Go deeper on NCT03837938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837938.